Characterizing mixed location hemorrhages/microbleeds with CSF markers
- PMID: 36622021
- DOI: 10.1177/17474930231152124
Characterizing mixed location hemorrhages/microbleeds with CSF markers
Abstract
Objective: Cerebral amyloid angiopathy (CAA) is a common cause of lobar and subarachnoid hemorrhages in the elderly. A diagnosis of CAA requires multiple lobar hemorrhagic lesions (intracerebral hemorrhage and/or cerebral microbleeds) and/or cortical superficial siderosis (cSS). In contrast, hemorrhagic lesions located in the deep structures are the hallmark of hypertensive arteriopathy (HTN-A). They are an exclusion criterion for CAA, and when present with lobar hemorrhagic lesions considered a separate entity: mixed location hemorrhages/microbleeds (MLHs). We compared clinical, radiological, and cerebrospinal fluid (CSF) marker data in patients with CAA, MLH, and Alzheimer's disease (AD), and healthy controls (HCs) and used it to position MLH in the disease spectrum.
Patients and methods: Retrospective cohort study of consecutive patients with CAA (n = 31), MLH (n = 31), AD (n = 28), and HC (n = 30). Analysis of clinical, radiological, CSF biomarker (Aß42, Aß40, t-tau, and p-tau), and histopathological data in patients each group.
Results: cSS was significantly more common in CAA than MLH (45% vs 13%, p = 0.011), and cSS in MLH was associated with intracerebral hemorrhage (ICH) (p = 0.037). Aß42 levels and the Aß42/Aß40 ratio, diagnostic groups followed the order HC > MLH > CAA > AD and the opposite order for t-tau and p-tau. No clear order was apparent forAß40. Aß40 and Aß42 levels as well as the Aß42/Aß40 ratio were lower in both CAA and MLH patients with cSS than in patients without cSS. Aß40 and Aß42 levels were higher in CAA and MLH patients with lacunar infarcts than in those without.
Conclusion: Our data suggest that MLH and CAA are mutually not exclusive diagnoses, and are part of a spectrum with variable contributions of both CAA and HTN-A.
Keywords: Cerebral amyloid angiopathy; amyloid Aß40; amyloid Aß42; cerebrospinal fluid; cortical superficial siderosis; mixed location hemorrhage/microbleeds; modified Boston criteria.
Similar articles
-
Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy.Neurology. 2013 Aug 13;81(7):626-32. doi: 10.1212/WNL.0b013e3182a08f2c. Epub 2013 Jul 17. Neurology. 2013. PMID: 23864315
-
Mechanistic Implications of Cortical Superficial Siderosis in Patients With Mixed Location Intracerebral Hemorrhage and Cerebral Microbleeds.Neurology. 2023 Aug 8;101(6):e636-e644. doi: 10.1212/WNL.0000000000207476. Epub 2023 Jun 8. Neurology. 2023. PMID: 37290968 Free PMC article.
-
Brain hemorrhage on 24h-CT and functional outcome in stroke patients with cerebral amyloid angiopathy features on pre-thrombolysis MRI treated with intravenous thrombolysis: A case series.J Stroke Cerebrovasc Dis. 2023 Feb;32(2):106907. doi: 10.1016/j.jstrokecerebrovasdis.2022.106907. Epub 2022 Nov 25. J Stroke Cerebrovasc Dis. 2023. PMID: 36442282
-
Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis.Stroke. 2022 Jun;53(6):1944-1953. doi: 10.1161/STROKEAHA.121.035836. Epub 2022 Mar 10. Stroke. 2022. PMID: 35264008
-
Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis.Int J Stroke. 2019 Oct;14(7):723-733. doi: 10.1177/1747493019830065. Epub 2019 Feb 20. Int J Stroke. 2019. PMID: 30785378
Cited by
-
Frequency of deep-seated cerebral microbleeds in patients with lobar hemorrhages and histopathological evidence for cerebral amyloid angiopathy.Front Neurol. 2023 Apr 12;14:1146737. doi: 10.3389/fneur.2023.1146737. eCollection 2023. Front Neurol. 2023. PMID: 37122304 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical